Tech Company Financing Transactions

Ritter Pharmaceuticals Funding Round

Ritter Pharmaceuticals closed a $3.7 million funding round on 12/31/2014. Backers included Javelin Venture Partners.

Transaction Overview

Announced On
12/31/2014
Transaction Type
Venture Equity
Amount
$3,694,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1880 Century Park East 1000
Los Angeles, CA 90067
USA
Email Address
Overview
Ritter (NASDAQ: RTTR) is committed to the discovery, development and commercialization of novel therapeutic treatments for gastrointestinal diseases and conditions.
Profile
Ritter Pharmaceuticals LinkedIn Company Profile
Social Media
Ritter Pharmaceuticals Company Twitter Account
Company News
Ritter Pharmaceuticals News
Facebook
Ritter Pharmaceuticals on Facebook
YouTube
Ritter Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Ritter
  Andrew Ritter LinkedIn Profile  Andrew Ritter Twitter Account  Andrew Ritter News  Andrew Ritter on Facebook
VP - Bus. Development
Ira Ritter
  Ira Ritter LinkedIn Profile  Ira Ritter Twitter Account  Ira Ritter News  Ira Ritter on Facebook
VP - Finance
John Beck
  John Beck LinkedIn Profile  John Beck Twitter Account  John Beck News  John Beck on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/31/2014: Arsia Therapeutics venture capital transaction
Next: 12/31/2014: Exablox venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary